{"id":158,"date":"2024-05-08T17:18:01","date_gmt":"2024-05-08T17:18:01","guid":{"rendered":"https:\/\/www.merckvaccines.com\/vaqta\/?page_id=158"},"modified":"2026-03-26T09:24:40","modified_gmt":"2026-03-26T09:24:40","slug":"adult-efficacy-immunogenicity","status":"publish","type":"page","link":"https:\/\/www.merckvaccines.com\/vaqta\/adult-efficacy-immunogenicity\/","title":{"rendered":"Efficacy and Immunogenicity \u2013 Adult"},"content":{"rendered":"<link rel='stylesheet' id='vivid360-spacer-css-css' href='https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/themes\/cex-wpvip-mhh-merck-vivid360-theme-1-12\/blocks\/spacer\/css\/style.min.css?ver=1765194012' media='all' \/>\n\n<div style=\"background-color:transparent;height:8px\" class=\"wp-block-vivid360-spacer vivid360-spacer spacer-8\"><\/div>\n\n\n<link rel='stylesheet' id='vivid360-hero-css-css' href='https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/themes\/cex-wpvip-mhh-merck-vivid360-theme-1-12\/blocks\/hero\/css\/style.min.css?ver=1765194012' media='all' \/>\n\n<div id=\"\" class=\"wp-block-vivid360-hero\"><div class=\"vivid360-hero-container align-left align-middle ratio-70-30 horizontal mobile text-align-left has-primary-dark-color is-default-style mobile-is-default-style mobile-uses-custom-styles\" style=\"border-width:0;border-style:solid;border-top-left-radius:0;border-top-right-radius:0;border-bottom-right-radius:0;border-bottom-left-radius:0;--minHeight:244px;--mobileMinHeight:154px\"><div class=\"wide_screens hidden\" data-value=\"stretch\"><\/div><picture><source media=\"(max-width: 767px)\" srcset=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/DA_Flexible-Dosing-Schedule_Adults_Banner_1128px@2x-3.png?w=767\"\/><source media=\"(min-width: 768px) and (max-width: 1024px)\" srcset=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/DA_Flexible-Dosing-Schedule_Adults_Banner_1128px@2x-3.png?w=1024\"\/><source media=\"(min-width: 1025px) and (max-width:1440px)\" srcset=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/DA_Flexible-Dosing-Schedule_Adults_Banner_1128px@2x-3.png?w=1440\"\/><img decoding=\"async\" width=\"2257\" height=\"485\" loading=\"lazy\" data-src=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/DA_Flexible-Dosing-Schedule_Adults_Banner_1128px@2x-3.png?w=1488\" src=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/DA_Flexible-Dosing-Schedule_Adults_Banner_1128px@2x-3.png?w=1488\" alt=\"\" class=\"hero-image\" style=\"--desktop-focal-x:50%;--desktop-focal-y:50%;--mobile-focal-x:50%;--mobile-focal-y:50%;--tablet-focal-x:50%;--tablet-focal-y:50%\"\/><div class=\"capoverlay-container-mobile right-bottom show  hide_mobile isMobileOverlayChecked label\" style=\"--top-margin:;--bottom-margin:;--left-margin:;--right-margin:\"><div class=\"overlay-caption-schema\">Actor Portrayal<\/div><\/div><\/picture><div class=\"hero-wrapper\"><div class=\"hero-content\"><h1 style=\"--headlineFontSize:36px;--headlineFontSizeTablet:36px;--headlineFontSizeMobile:24px;--headlineLineHeight:45px;--headlineLineHeightTablet:45px;--headlineLineHeightMobile:30px\" class=\"hero-title fontWeightRegular\"><strong>VAQTA\u00ae (Hepatitis A Vaccine, Inactivated) \u2028Adult clinical data \u2013 efficacy and \u2028immunogenicity<\/strong><\/h1><p class=\"hero-description\"><\/p><div class=\"hero-btn-group\">\n\n<p><\/p>\n\n<\/div><div class=\"hero-caption\"><\/div><\/div><\/div><\/div><div class=\"hero-caption-2mobile\"><\/div><\/div>\n\n\n\n<div style=\"background-color:transparent;height:8px\" class=\"wp-block-vivid360-spacer vivid360-spacer spacer-8\"><\/div>\n\n\n<link rel='stylesheet' id='vivid360-heading-css-css' href='https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/themes\/cex-wpvip-mhh-merck-vivid360-theme-1-12\/blocks\/heading\/css\/style.min.css?ver=1765194012' media='all' \/>\n\n<div class=\"vivid360-heading default-hcp-tablet-fontsize\" id=\"a8de3909d-58e4-486a-9943-04b98ea00cad\"><h2 class=\"has-primary-dark-color content-width fontWeightRegular\" style=\"--desktopFontSize:24px;--tabletFontSize:var(--h2FontSizeDesktop);--mobileFontSize:18px;--desktopLineHeightSize:36px;--tabletLineHeightSize:var(--h2LineHeightDesktop);--mobileLineHeightSize:\" id=\"\"><strong>Proven efficacy in adult patients. VAQTA showed:<\/strong><\/h2><\/div>\n\n\n\n<div style=\"background-color:transparent;height:16px\" class=\"wp-block-vivid360-spacer vivid360-spacer spacer-16\"><\/div>\n\n\n\n<div class=\"wp-block-columns ml-0 mb-0 is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column ml-0 mr-0 mb-0 is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:15%\"><\/div>\n\n\n\n<div class=\"wp-block-column ml-0 mr-0 mt-0 mb-0 is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:30%\"><link rel='stylesheet' id='vivid360-image-css-css' href='https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/themes\/cex-wpvip-mhh-merck-vivid360-theme-1-12\/blocks\/image\/css\/style.min.css?ver=1777396162' media='all' \/>\n\n<div class=\"wp-block-vivid360-image img-container mr-0  ml-0 mt-0 mb-0\"><figure class=\"wp-block-vivid360-image is-style-default has-mobile-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"524\" height=\"210\" src=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/99.9-Seroconversion-4-weeks-after-dose-2_BOX-VISUAL@2x.png\" alt=\"Robust Immunogenicity After 2 Doses in Clinical Trials that Included Adults 19 Years of Age and Older, VAQTA\u00ae (Hepatitis A Vaccine, Inactivated) Demonstrated 99.9% Seroconversion 4 Weeks After Dose 2\" class=\"wp-image-3225  style-noshadow deskHeightAuto deskWidthAuto \" style=\"height:210px;width:524px\" srcset=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/99.9-Seroconversion-4-weeks-after-dose-2_BOX-VISUAL@2x.png 524w, https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/99.9-Seroconversion-4-weeks-after-dose-2_BOX-VISUAL@2x.png?resize=300,120 300w\" sizes=\"auto, (max-width: 524px) 100vw, 524px\" \/><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/99.9-Seroconversion-4-weeks-after-dose-2_BOX-VISUAL@2x.png\" alt=\"Robust Immunogenicity After 2 Doses in Clinical Trials that Included Adults 19 Years of Age and Older, VAQTA\u00ae (Hepatitis A Vaccine, Inactivated) Demonstrated 99.9% Seroconversion 4 Weeks After Dose 2\" class=\"wp-image-3225  style-noshadow mobile-image mobHeightAuto mobWidthAuto \" width=\"350\" height=\"180\" title=\"\" style=\"height:180px;width:350px\"\/><\/figure><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:5%\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:30%\">\n<div class=\"wp-block-vivid360-image img-container ml-0 mr-0 mt-0\"><figure class=\"wp-block-vivid360-image is-style-default has-mobile-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"524\" height=\"210\" src=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/99.4-Seroconversion-Rates-after-6-Years_BOX-VISUAL@2x.png\" alt=\"Sustained Immunogenicity for at Least 6 Years in a Clinical Study of Adult Subjects Who Received 2 Doses of VAQTA\u00ae (Hepatitis A Vaccine, Inactivated) 6 Months Apart: 99.4% Seroconversion Rates After 6 Years\" class=\"wp-image-3226  style-noshadow deskHeightAuto deskWidthAuto \" style=\"height:210px;width:524px\" srcset=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/99.4-Seroconversion-Rates-after-6-Years_BOX-VISUAL@2x.png 524w, https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/99.4-Seroconversion-Rates-after-6-Years_BOX-VISUAL@2x.png?resize=300,120 300w\" sizes=\"auto, (max-width: 524px) 100vw, 524px\" \/><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/99.4-Seroconversion-Rates-after-6-Years_BOX-VISUAL@2x.png\" alt=\"Sustained Immunogenicity for at Least 6 Years in a Clinical Study of Adult Subjects Who Received 2 Doses of VAQTA\u00ae (Hepatitis A Vaccine, Inactivated) 6 Months Apart: 99.4% Seroconversion Rates After 6 Years\" class=\"wp-image-3226  style-noshadow mobile-image mobHeightAuto mobWidthAuto \" width=\"350\" height=\"180\" title=\"\" style=\"height:180px;width:350px\"\/><\/figure><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:15%\"><\/div>\n<\/div>\n\n\n\n<div style=\"background-color:transparent;--desktop-spacer:2px;--mobile-spacer:8px;--tablet-spacer:2px\" class=\"wp-block-vivid360-spacer vivid360-spacer-desktop vivid360-spacer-mobile vivid360-spacer-tablet\"><\/div>\n\n\n\n<div class=\"vivid360-heading\" id=\"a890435e0-e65d-4f12-bdb1-d8e1ef43921a\"><h3 class=\"has-primary-dark-color content-width fontWeightRegular\" style=\"--desktopFontSize:20px;--tabletFontSize:var(--h3FontSizeDesktop);--mobileFontSize:18px;--desktopLineHeightSize:30px;--tabletLineHeightSize:var(--h3LineHeightDesktop);--mobileLineHeightSize:\" id=\"\"><strong>Clinical study design<\/strong><\/h3><\/div>\n\n\n\n<div style=\"background-color:transparent;height:16px\" class=\"wp-block-vivid360-spacer vivid360-spacer spacer-16\"><\/div>\n\n\n\n<p class=\"has-text-color has-link-color has-regular-font-size wp-elements-b8fdf271ab853f68d6efd49ddc9635d3\" style=\"color:#333333\"><sup>a<\/sup>Immunogenicity data were combined from 5 randomized clinical studies in adults 19 years of age and older who received 2 total doses of VAQTA (50 U\/1-mL) given 6 months apart. These patients had a geometric mean titer (GMT) of 6013 mIU\/mL (95% CI: 5592, 6467) after the second dose. The efficacy of VAQTA in adults 19 years of age and older was based upon immunogenicity measured 4 to 6 weeks following vaccination.<br><br><sup>b<\/sup>In another clinical study that evaluated adults who received VAQTA at 0 and 6 months, 99.4% (170\/171) of subjects still had detectable levels of anti-hepatitis A antibodies 6 years later. Six years postvaccination, patients had a GMT of 684 mIU\/mL.<br><br>Anti-HAV antibodies \u226510 mIU\/mL indicate seroconversion.<\/p>\n\n\n\n<div style=\"background-color:transparent;height:16px\" class=\"wp-block-vivid360-spacer vivid360-spacer spacer-16\"><\/div>\n\n\n<link rel='stylesheet' id='vivid360-separator-css-css' href='https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/themes\/cex-wpvip-mhh-merck-vivid360-theme-1-12\/blocks\/separator\/css\/style.min.css?ver=1765194012' media='all' \/>\n\n<hr class=\"wp-block-vivid360-separator has-text-color has-background has-medium-gray-background-color has-medium-gray-color full-page-width\" style=\"height:0\"\/>\n\n\n\n<div style=\"background-color:transparent;height:8px\" class=\"wp-block-vivid360-spacer vivid360-spacer spacer-8\"><\/div>\n\n\n\n<div class=\"vivid360-heading default-hcp-tablet-fontsize\" id=\"a1404100e-3d28-4405-8f06-8b160135820d\"><h2 class=\"has-primary-dark-color content-width fontWeightRegular\" style=\"--desktopFontSize:24px;--tabletFontSize:var(--h2FontSizeDesktop);--mobileFontSize:18px;--desktopLineHeightSize:36px;--tabletLineHeightSize:var(--h2LineHeightDesktop);--mobileLineHeightSize:\" id=\"\"><strong>Antibody persistence<\/strong><\/h2><\/div>\n\n\n\n<div style=\"background-color:transparent;--desktop-spacer:8px;--mobile-spacer:8px;--tablet-spacer:8px\" class=\"wp-block-vivid360-spacer vivid360-spacer-desktop vivid360-spacer-mobile vivid360-spacer-tablet\"><\/div>\n\n\n\n<div class=\"vivid360-heading\" id=\"aa1b4ffbd-558d-408b-987e-38f0dd2346aa\"><h3 class=\"has-primary-dark-color content-width fontWeightRegular\" style=\"--desktopFontSize:20px;--tabletFontSize:var(--h3FontSizeDesktop);--mobileFontSize:18px;--desktopLineHeightSize:30px;--tabletLineHeightSize:var(--h3LineHeightDesktop);--mobileLineHeightSize:\" id=\"\"><strong>6-year response demonstrated in adults who received VAQTA<\/strong><\/h3><\/div>\n\n\n\n<div class=\"paragraph-wrapper wp-elements-ab40a4b389554734d781c274cecce12d\"><div class=\"_393cc601-df8e-4f51-9ecf-a6d1dc92e8af \" id=\"\"><p class=\"has-text-color has-link-color has-regular-font-size\" style=\"color:#333333\">In a clinical study, hepatitis A antibody response in adults who were administered 2 doses of VAQTA 6 months apart was shown to persist for at least 6 years.<\/p><\/div><\/div>\n\n\n\n<div style=\"background-color:transparent;height:8px\" class=\"wp-block-vivid360-spacer vivid360-spacer spacer-8\"><\/div>\n\n\n\n<div class=\"wp-block-vivid360-image img-container ml-0 mr-0\"><figure class=\"wp-block-vivid360-image is-style-default has-mobile-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1128\" height=\"184\" src=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/image-10.svg?w=1024\" alt=\"Detectable Levels of Anti-HAV Antibodies in Adults Present in 100% of Subjects at 1 Year, 99.2% of Subjects at 2 to 3 Years, 99.1% of Subjects at 4 Years, and 99.4% of Subjects at 6 Years\" class=\"wp-image-3227  style-noshadow deskHeightAuto deskWidthAuto \" style=\"height:184px;width:1128px\" srcset=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/\/2026\/03\/image-10.svg 1128w, https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/\/2026\/03\/image-10.svg?resize=300,49 300w, https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/\/2026\/03\/image-10.svg?resize=768,125 768w, https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/\/2026\/03\/image-10.svg?resize=1024,167 1024w\" sizes=\"auto, (max-width: 1128px) 100vw, 1128px\" \/><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/Detectable-levels-of-anti-HAV-antibodies_BOX-VISUAL-MOBILE.svg\" alt=\"Detectable Levels of Anti-HAV Antibodies in Adults Present in 100% of Subjects at 1 Year, 99.2% of Subjects at 2 to 3 Years, 99.1% of Subjects at 4 Years, and 99.4% of Subjects at 6 Years\" class=\"wp-image-3228  style-noshadow mobile-image mobHeightAuto mobWidthAuto \" width=\"375\" height=\"515\" title=\"\" style=\"height:515px;width:375px\" srcset=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/\/2026\/03\/Detectable-levels-of-anti-HAV-antibodies_BOX-VISUAL-MOBILE.svg 375w, https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/\/2026\/03\/Detectable-levels-of-anti-HAV-antibodies_BOX-VISUAL-MOBILE.svg?resize=218,300 218w\" sizes=\"auto, (max-width: 375px) 100vw, 375px\" \/><\/figure><\/div>\n\n\n\n<div style=\"background-color:transparent;height:8px\" class=\"wp-block-vivid360-spacer vivid360-spacer spacer-8\"><\/div>\n\n\n\n<div class=\"paragraph-wrapper wp-elements-e274598ff689567a732abe97e5d47594\"><div class=\"_fc37ee8a-f4cc-4c75-b61f-68c2db49a5a8 \" id=\"\"><p class=\"has-text-color has-link-color has-regular-font-size\" style=\"color:#333333\">HAV, hepatitis A virus.<br><br>Anti-HAV antibodies \u226510 mIU\/mL indicate seroconversion.<br><br>The total duration of the protective effect of VAQTA in healthy vaccinees is unknown at present.<\/p><\/div><\/div>\n\n\n\n<div style=\"background-color:transparent;height:8px\" class=\"wp-block-vivid360-spacer vivid360-spacer spacer-8\"><\/div>\n\n\n\n<div class=\"paragraph-wrapper wp-elements-eb3c2c3214d49e77b3f3eaa0a7a330fd\"><div class=\"_e9d1f1d3-5e1c-4727-b283-7b80ef57e42e \" id=\"\"><p class=\"has-text-color has-link-color has-regular-font-size\" style=\"color:#333333\"><a href=\"https:\/\/www.merckvaccines.com\/vaqta\/adult-dosing-schedule\/\" aria-label=\"#\">View Adult Flexible Dosing Schedule<\/a><\/p><\/div><\/div>\n\n\n\n<div style=\"background-color:transparent;--desktop-spacer:32px;--tablet-spacer:32px;--mobile-spacer:32px;height:32px\" class=\"wp-block-vivid360-spacer vivid360-spacer-desktop vivid360-spacer-tablet vivid360-spacer-mobile\"><\/div>\n\n\n\n<hr class=\"wp-block-vivid360-separator has-text-color has-background has-medium-gray-background-color has-medium-gray-color full-page-width\" style=\"height:0\"\/>\n","protected":false},"excerpt":{"rendered":"<p>aImmunogenicity data were combined from 5 randomized clinical studies in adults 19 years of age and older who received 2 total doses&#8230;<\/p>\n","protected":false},"author":709,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_trash_the_other_posts":false,"editor_notices":[],"footnotes":""},"ga4_page_audience":[],"ga4_page_birn_id":[],"ga4_page_branding":[226],"ga4_page_businessunit":[234],"ga4_page_campaign":[],"ga4_page_content_purpose":[275],"ga4_page_customer_journey_stage":[294],"ga4_page_customer_specialty":[348],"ga4_page_experience":[],"ga4_page_indication":[405],"ga4_page_material_intent":[481],"ga4_page_product":[621],"ga4_page_region":[708],"ga4_page_therapeuticarea":[724],"class_list":["post-158","page","type-page","status-publish"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Adult Efficacy &amp; Immunogenicity With VAQTA\u00ae (Hepatitis A Vaccine, Inactivated)<\/title>\n<meta name=\"description\" content=\"Find efficacy and immunogenicity data for adult patients after receiving VAQTA\u00ae (Hepatitis A Vaccine, Inactivated), including antibody persistence data.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.merckvaccines.com\/vaqta\/adult-efficacy-immunogenicity\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adult Efficacy &amp; Immunogenicity With VAQTA\u00ae (Hepatitis A Vaccine, Inactivated)\" \/>\n<meta property=\"og:description\" content=\"Find efficacy and immunogenicity data for adult patients after receiving VAQTA\u00ae (Hepatitis A Vaccine, Inactivated), including antibody persistence data.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.merckvaccines.com\/vaqta\/adult-efficacy-immunogenicity\/\" \/>\n<meta property=\"og:site_name\" content=\"vaqta-mv\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-26T09:24:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/DA_Flexible-Dosing-Schedule_Adults_Banner_1128px@2x-3.png?w=1488\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adult Efficacy & Immunogenicity With VAQTA\u00ae (Hepatitis A Vaccine, Inactivated)","description":"Find efficacy and immunogenicity data for adult patients after receiving VAQTA\u00ae (Hepatitis A Vaccine, Inactivated), including antibody persistence data.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.merckvaccines.com\/vaqta\/adult-efficacy-immunogenicity\/","og_locale":"en_US","og_type":"article","og_title":"Adult Efficacy & Immunogenicity With VAQTA\u00ae (Hepatitis A Vaccine, Inactivated)","og_description":"Find efficacy and immunogenicity data for adult patients after receiving VAQTA\u00ae (Hepatitis A Vaccine, Inactivated), including antibody persistence data.","og_url":"https:\/\/www.merckvaccines.com\/vaqta\/adult-efficacy-immunogenicity\/","og_site_name":"vaqta-mv","article_modified_time":"2026-03-26T09:24:40+00:00","og_image":[{"url":"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/DA_Flexible-Dosing-Schedule_Adults_Banner_1128px@2x-3.png?w=1488","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.merckvaccines.com\/vaqta\/adult-efficacy-immunogenicity\/","url":"https:\/\/www.merckvaccines.com\/vaqta\/adult-efficacy-immunogenicity\/","name":"Adult Efficacy & Immunogenicity With VAQTA\u00ae (Hepatitis A Vaccine, Inactivated)","isPartOf":{"@id":"https:\/\/www.merckvaccines.com\/vaqta\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.merckvaccines.com\/vaqta\/adult-efficacy-immunogenicity\/#primaryimage"},"image":{"@id":"https:\/\/www.merckvaccines.com\/vaqta\/adult-efficacy-immunogenicity\/#primaryimage"},"thumbnailUrl":"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/DA_Flexible-Dosing-Schedule_Adults_Banner_1128px@2x-3.png?w=1488","datePublished":"2024-05-08T17:18:01+00:00","dateModified":"2026-03-26T09:24:40+00:00","description":"Find efficacy and immunogenicity data for adult patients after receiving VAQTA\u00ae (Hepatitis A Vaccine, Inactivated), including antibody persistence data.","breadcrumb":{"@id":"https:\/\/www.merckvaccines.com\/vaqta\/adult-efficacy-immunogenicity\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.merckvaccines.com\/vaqta\/adult-efficacy-immunogenicity\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.merckvaccines.com\/vaqta\/adult-efficacy-immunogenicity\/#primaryimage","url":"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/DA_Flexible-Dosing-Schedule_Adults_Banner_1128px@2x-3.png","contentUrl":"https:\/\/www.merckvaccines.com\/vaqta\/wp-content\/uploads\/sites\/163\/2026\/03\/DA_Flexible-Dosing-Schedule_Adults_Banner_1128px@2x-3.png","width":2257,"height":485},{"@type":"BreadcrumbList","@id":"https:\/\/www.merckvaccines.com\/vaqta\/adult-efficacy-immunogenicity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.merckvaccines.com\/vaqta\/"},{"@type":"ListItem","position":2,"name":"Efficacy and Immunogenicity \u2013 Adult"}]},{"@type":"WebSite","@id":"https:\/\/www.merckvaccines.com\/vaqta\/#website","url":"https:\/\/www.merckvaccines.com\/vaqta\/","name":"vaqta-mv","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.merckvaccines.com\/vaqta\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/pages\/158","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/users\/709"}],"replies":[{"embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/comments?post=158"}],"version-history":[{"count":194,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/pages\/158\/revisions"}],"predecessor-version":[{"id":3270,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/pages\/158\/revisions\/3270"}],"wp:attachment":[{"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/media?parent=158"}],"wp:term":[{"taxonomy":"ga4_page_audience","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_audience?post=158"},{"taxonomy":"ga4_page_birn_id","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_birn_id?post=158"},{"taxonomy":"ga4_page_branding","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_branding?post=158"},{"taxonomy":"ga4_page_businessunit","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_businessunit?post=158"},{"taxonomy":"ga4_page_campaign","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_campaign?post=158"},{"taxonomy":"ga4_page_content_purpose","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_content_purpose?post=158"},{"taxonomy":"ga4_page_customer_journey_stage","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_customer_journey_stage?post=158"},{"taxonomy":"ga4_page_customer_specialty","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_customer_specialty?post=158"},{"taxonomy":"ga4_page_experience","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_experience?post=158"},{"taxonomy":"ga4_page_indication","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_indication?post=158"},{"taxonomy":"ga4_page_material_intent","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_material_intent?post=158"},{"taxonomy":"ga4_page_product","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_product?post=158"},{"taxonomy":"ga4_page_region","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_region?post=158"},{"taxonomy":"ga4_page_therapeuticarea","embeddable":true,"href":"https:\/\/www.merckvaccines.com\/vaqta\/wp-json\/wp\/v2\/ga4_page_therapeuticarea?post=158"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}